-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gait disturbances are common and disabling in patients with Parkinson's disease (PD)
Figure 1: Paper cover image
Since dopaminergic drug therapy and deep brain stimulation often have only modest effects on gait disturbances, the application of compensatory strategies has become an important part of PD gait rehabilitation
To date, PD's compensation strategies have often been reported in the form of case reports
Using this, Anouk Tosserams et al.
Main objectives:
They recruited PD patients and self-reported disabling gait disorders to participate in this laboratory-based within-subject study
Gait assessment consisted of six consecutive 3-minute walk trials on a 6-meter-long walkway
Trials included: 1) baseline gait; 2) external cues; 3) internal cues; 4) movement observation; 5) motor imagery; and 6) adoption of new walking patterns
101 participants (50 males; median [range] age: 66 [47-91] years) were included
Figure 2: The results of the paper
The effects of different strategies varied widely among participants
Higher MoCA scores were associated with greater effects of external cues
The significance of this study lies in the findings that support the use of compensatory strategies in gait rehabilitation in PD, but underscore the importance of an individualized approach
Original source:
